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The structural basis ofidiotypic antigens has been studied intensively in murine 
model systems (1), but less thoroughly in humans.  Analyses of idiotype-antiidi- 
otype reactions may be important  in understanding  the pathogenesis of human 
immunologic diseases, and in developing new approaches to treatment.  Kunkel 
and coworkers (2), and subsequently Powell and Agnello (3), showed that  IgM 
anti-IgG  autoantibodies  (rheumatoid  factors  [RF]) from  unrelated  individuals 
may display crossreactive idiotypes. The  heavy and light chain  variable region 
sequences of several IgM-RF have been reported (4-6). However, genetic studies 
and hybridoma techniques are difficult to apply in an outbred human population. 
Therefore,  we have  taken  a  different  approach  toward  defining  relationships 
between idiotype and structure on these human  Ig. Rabbit antisera were gener- 
ated against synthetic peptides with sequences corresponding to the hypervariable 
regions (complementarity determining regions [CDR]), of human  IgM-RF. The 
antipeptide antibodies enabled us to clarify the structural basis for a private (7) 
and a crossreactive (8) idiotype on the anti-IgG autoantibodies. 
Recent results in mice (9,  10), and our own preliminary data in humans (1 1), 
have focused attention on the third CDR of the heavy chain as a site of dominant 
idiotype formation. We now report that antisera raised against synthetic peptides 
corresponding  to  the  third  heavy chain  CDR consistently  recognize  idiotypes 
expressed  by intact  IgM-RF autoantibodies.  In  contrast,  high-titer  antibodies 
against  synthetic peptides representing  the  first and  second heavy chain  CDR 
infrequently  bind  to the  IgM-RF molecule.  These  results  suggest a  distinctive 
role of the  D (diversity-generating) region in the generation  of idiotypic deter- 
minants, and have implications concerning the manipulation  of idiotype-antiidi- 
otype reactions in patients. 
Materials and Methods 
Preparation  of Synthetic  Peptides.  The  methods  for  peptide  synthesis,  coupling  to 
keyhole limpet hemocyanin (KLH), and immunization  of rabbits with the peptide-protein 
This work was supported by grants AM07144, AM25443, AG04100, and AM35218 from the 
National Institutes of Health, Bethesda, MD. This is publication 3911BCR from the  Research 
Institute of Scripps Clinic, La Jolla, CA. 
756  J. ExP. MED. © The Rockefeller  University Press • 0022-1007/85/8/0756/06 $1.00 
Volume 162  August  1985  756-761 GOLDFIEN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Amino Acid Sequences of Peptides 
Residues 
Name*  spanned*  Amino acid sequence 
1. PPH 1  22-35 
2. PPH2  49-65 
3. PPH3  95-102 
4. PSHI  22-35 
5. PSH2  49-65 
6. PSH3  95-102 
7. PWH2  49-65 
8. PWH3  95-102 
AASGFTFSSSAMSC 0 
AW KYENGNDKHYADSVNG(GGC) 0 
DAGPYVSPTFFAH(GGC) j 
KTSGGTFSGYTISO 
GSPAKWTDPFQGVYIKWE(GGC) I 
EWKGQVNVNPFDY(GGC) m 
GQI PLRFNGEVKN PGSVV(GGC) ~ 
EYGFDTSDYYYYY(GGC) i 
* The abbreviation, PXHN,  describes the peptides, P;  X, the cognate protein (P, 
Pore; S,  Sie; W,  Wol);  H, the  heavy chain; and  N  denotes the first, second, or 
third CDR. 
* Numbering is after Kabat et al. (16). 
a Sequences reported by Capra and Kehoe (4). 
I Sequences reported by Andrews and Capra (5). 
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conjugates have been  previously described in  detail  (7,  8).  Briefly, the  peptides  were 
synthesized by Merrifield's solid-phase method (12), slightly modified (8). The derivation 
and sequences of the peptides are given in Table I. Rabbits were injected twice with the 
peptide-conjugates emulsified in  complete Freund's adjuvant,  and  were boosted twice 
with glutaraldehyde-crosslinked peptides in incomplete Freund's adjuvant, as reported 
earlier (7). In some cases, rabbits were injected once with conjugates in complete Freund's 
adjuvant,  and  boosted  with  conjugates  in  incomplete  Freund's  adjuvant.  Sera  were 
obtained at biweekly intervals after immunization, and were stored in 0.02% sodium azide 
at -20°C. 
Purification of Proteins.  Plasma or purified proteins were generously provided by Drs. 
J.  D.  Capra  (Univ.  Texas  Health  Sciences Center,  Dallas,  TX),  G.  Abraham  (Univ. 
Rochester School of Medicine, Rochester, NY), J. Johnson (Nashville,  TN), H. Metzger 
(National Institutes of Health, Bethesda, MD), and V. Agnello (Lahey Clinic,  Burlington, 
MA). IgM cryoglobulins were prepared as described (11). 
Enzyme-linked Immunosorbant Assay (ELISA).  The ELISA method for detecting anti- 
peptide and anti-RF antibodies has been reported previously (8). 
Immunoblotting.  Protein samples (20 #g each) were loaded onto 10% polyacrylamide 
gels containing 0.1% sodium dodecyl sulfate, and were electrophoresed at 30 mA for 3 
h. The proteins were then transferred to nitrocellulose paper electrophoretically (70 V 
for 1.5-2 h). Protein binding sites on the papers were blocked with 5% powdered milk in 
borate-buffered saline (BBS). Rabbit antiserum, diluted in 2% powdered milk-BBS,  was 
added, and incubated for 1 h. Finally, after extensive washing with BBS, the papers were 
incubated with ~25I-protein A (1 mCi/mg, 2 ×  10  "~ cpm/ml), for 1 h, washed, and exposed 
overnight to Kodak XAR-5 film. 
Results 
Production  of Antipeptide Antibodies.  The sequences of the synthetic peptides 
used are listed in Table I. Antibodies against each peptide-KLH conjugate were 
prepared in at least two rabbits, which were bled biweekly. All serum specimens 
were tested  by  ELISA  for peptide-binding activity.  Fig.  1 shows  that,  in  each 
case,  high titers of antipeptide antibodies were elicited.  None of the antibodies 
bound  significantly to an  irrelevant peptide (PWL3).  Pooled serum  from non- 
immune rabbits did not react substantially with the peptide-coated plates (data 
not  shown).  Thus,  all  the  peptides  studied  were  immunogenic.  There was  no 
apparent correlation between the sequence of the CDR peptide and the degree 
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FIGURE  1.  Reactivity  of antipeptide  antibodies  with  the  immunizing  peptides  in  ELISA. 
Plates were  precoated  with  10  ug/ml  of peptides,  and  reacted  with  increasing dilutions of 
corresponding  antisera,  followed by alkaline phosphatase-labeled  goat anti-rabbit  antibody. 
The  closed  symbols  represent  binding of antisera  to  immunizing  peptide:  (O),  CDR1;  (I), 
CDR2; (&), CDR3.  The  open symbols represent binding to the irrelevant peptide PWL3  (O), 
CDR1; (1-1), CDR2; (A), CDR3.  Binding is expressed as optical density (OD) X  l0 s at 405 nm, 
at  30  min after addition of substrate.  Points represent  the  mean  of duplicate determinants, 
with <5%  variability between replicates. 
TABLE  II 
Reactivity of Antipeptide Antibodies with a Panel of Human IgM-RF by Immunoblotting 
Antipeptide  IgM-RF antigen* 
m~tiserum  Pore  Sie  Wol  Les  Pay  Got  Glo  Neu  Gar  Cha  Sou  Mcd  Ark  TaI  BeI  Dri  BIo 
PPHI  +  -  -  - 
PPH2  +  -  -  - 
PPH3  +  -  -  - 
PSH 1  .... 
PSH2  .... 
PSH3  -  +  -  - 
PWH2  -  -  +  - 
PWH3  -  -  +  - 
--  m 
i  -- 
--  I 
--  i 
m  --  i  -- 
w 
A (+) denotes reactivity of the antipeptide antibody with tbe RF, as detected by immunoblotting. A (-) indicates lack of 
reactivity. 
* The IgM-RF Pore, Sie, Wol, Pay, Got, GIo, Neu, and Gar have been described (6).  Cha, Sou, Mcd, Ark, Tal, Bel, Dri, 
and BIo were the generous gift of Dr. V. Agnetlo (3). 
Reactivity  of Antipeptide  Antisera  by  Immunoblotting.  The  reactivity  of the 
antipeptide  antisera  with  isolated  heavy  chains  of IgM-RF  was  analyzed  by 
immunoblotting. The results are summarized in Table II. There are two points 
of note:  (a)  no antiserum reacted with more than a  single RF, and (b)  not all 
antisera reacted even  with the isolated heavy chain  of the  RF containing the 
immunizing sequence. Specifically, the anti-PSH1 and anti-PSH2 antisera failed 
to bind  to isolated Sie  heavy chain.  This has been a  consistent result,  despite 
repeated immunizations in several rabbits. 
In every case, antisera directed against the third CDR sequence reacted more 
strongly with the isolated heavy chain than did antisera directed against the first 
or second CDR. This result is illustrated in Fig. 2, which compares the reactivity 
of each antipeptide antiserum with its respective RF heavy chain. Although anti- GOLDFIEN  ET  AL.  BRIEF  DEFINITIVE  REPORT  759 
FIGURE 2.  Reactivity of antipeptide  antibodies with isolated  RF heavy chains by immuno- 
blotting. All antipeptide antisera  were diluted  1:20.  Binding was assessed  by binding of ~sI- 
protein A binding, followed by autoradiography. 
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FIGURE  3.  Reactivity of antipeptide antibodies with intact RF by ELISA. Plates were coated 
with  2  ug/ml  (Pore,  Sie)  or  10  t~g/ml  (Wol)  and  reacted  with  serial  dilutions  of antisera, 
followed by alkaline phosphatase-labeled  goat anti-rabbit antibody (@), CDR1; (I), CDR2; 
(4),  CDR3.  The  values represent  net OD  ×  10 s at  450  nm  betw'een test  sera  and pooled 
normal rabbit serum at equivalent dilution, measured at 60 rain after addition of substrate. 
PPH1  and anti-PWH2  appear  to be  unreactive in this figure,  they are  in  fact 
reactive with longer exposure (data not shown). 
Binding  of Antipeptide  Antisera  To Intact  RF by ELISA.  The  binding of the 
eight different antipeptide  antibodies  to  intact  IgM-RF  was  tested by  ELISA, 
using  microtiter  plates  coated  with  the  purified  RF  proteins,  and  increasing 
concentrations of antipeptide  antisera  (Fig.  3).  All  three  anti-CDR  3  antisera 
bound to the intact IgM-RF molecule. In contrast, of the five antibodies against 
CDR 1 and CDR 2 peptides, only anti-PPH2 reacted weU with the corresponding 
IgM-RF  protein.  As noted  earlier  (Fig.  1),  all  antisera  recognized  specifically, 
and in high titer, the immunizing CDR peptide. 
Discussion 
We  have  assessed  the  ability  of synthetic  peptides,  corresponding  to  heavy 
chain CDR sequences on human IgM-RF paraproteins,  to elicit specific antiidi- 
otypic antibodies.  At least two different rabbit antisera  were generated against 
eight different synthetic peptide-KLH  conjugates, representing all three heavy 760  GOLDFIEN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
chain CDR  of two monoclonal IgM-RF (Sie,  Pore), and the second and  third 
CDR of an additional IgM-RF (Wol). In all cases, potent and specific antipeptide 
antibodies were produced. However, only the antisera against the third heavy 
chain CDR reacted consistently with the corresponding heavy chain polypeptides, 
and  with  the  intact  IgM-RF  proteins.  These  results  with  synthetic  peptides 
strongly suggest that the third heavy chain CDR sequence is associated with an 
immunodominant idiotypic determinant. 
In the well-defined murine antidextran (13), antiphosphocholine (10), antiga- 
lactan  (14),  and antiarsonate  (9)  antibody systems, the  heavy chain  D  region 
segment has been shown to play an important role in the generation of immu- 
nodominant  idiotypes.  The  D  region  is  responsible  for  the  majority  of the 
sequence variability in the third CDR of mouse heavy chains, but often contrib- 
utes little to antigen binding specificity (13,  14).  In this regard, it is interesting 
to  note  tbat  the  third  heavy chain  CDR  may present an  exposed,  accessible 
surface on the Ig molecule, as predicted by computer modeling (14).  In human 
heavy chains, the D region boundaries are less well defined (15,  16).  However, 
it seems likely that the human D segment does constitute part of the third heavy 
chain CDR,  and contributes to its variability. Conceivably, a major function of 
antibody D region gene segments may be to generate idiotypic diversity, inde- 
pendently of effects on antigen binding. 
The ability of synthetic peptides to delineate the role of the heavy chain  D 
segment, and the third CDR,  in  the formation of immunodominant idiotypes 
has  clinical  implications.  Peptide-induced  antiidiotypes  provide  a  means  for 
comparing the primary structures of Ig of unknown sequence. However, to be 
useful  for  the  specific  modulation  of abnormal  Ig  production,  the  peptide- 
induced antibodies  probably  must  recognize the intact  cognate protein  in  its 
native form.  Our results suggest that  synthetic peptides corresponding to  the 
third CDR of human heavy chains can reproducibly elicit antiidiotypic antibodies 
against intact human IgM-RF paraproteins. 
Summary 
Synthetic peptides corresponding to eight individual heavy chain complemen- 
tarity-determining regions  (CDR)  of three  human  monoclonal  IgM  anti-IgG 
(rheumatoid factor [RF]) paraproteins elicited rabbit antibodies with markedly 
different properties. All antisera recognized the immunizing peptide, and several 
reacted with the isolated IgM heavy chain on immunoblots. However, only the 
antisera  against  peptides  representing the third  CDR  bound  consistently and 
specifically to  the intact  IgM-RF molecule. These data indicate that the third 
CDR of human #  chains comprises an immunodominant idiotype, and suggest 
that  the  D  gene  segment  may  be  especially important  in  creating  idiotypic 
diversity.  Synthetic peptides  corresponding to  the  third  heavy chain  CDR  of 
human paraproteins may be clinically useful for the specific induction of antiidi- 
otypic antibodies. 
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